Navigation Links
Researchers report first success of targeted therapy in most common non-small cell lung cancer
Date:11/28/2012

BOSTON - A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Published online today in The Lancet Oncology, the combination of chemotherapy and the targeted drug selumetinib was more effective than chemotherapy alone in a clinical trial involving patients with a form of non-small cell lung cancer (NSCLC) that carries a mutation in the gene KRAS a variety that represents about 20 percent of all NSCLC cases. Previously, no targeted agent, either alone or in combination with another drug, had proven beneficial in a trial involving patients with this type of NSCLC.

The 87 patients who participated in the new, phase II trial conducted at 67 sites around the world had advanced, KRAS-mutant NSCLC that had failed initial chemotherapy. The participants were randomly assigned to receive either selumetinib and the chemotherapy agent docetaxel or docetaxel alone.

Investigators found that while 37 percent of the patients in the selumetinib group experienced some shrinkage of their tumor, none of the patients in the docetaxel-only group did. Of particular significance, patients receiving selumetinib lived a median of 5.3 months before their cancer began to worsen, compared to 2.1 months for those receiving chemotherapy alone. (Patients in the selumetinib group also survived longer, on average, than those in the docetaxel group 9.4 months compared to 5.2 months but the improvement was not considered statistically significant.)

"Our findings suggest that selumetinib and docetaxel work synergistically each enhancing the effect of the other," says the study's lead author, Pasi A. Janne, MD, PhD, of Dana-Farber. "This opens the possibility that there may finally be a therapeutic strategy
'/>"/>

Contact: Robbin Ray
Robbin_Ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. USC, Oxford researchers find high fructose corn syrup-global prevalence of diabetes link
2. Researchers study cry acoustics to determine risk for autism
3. Researchers explore social media as preventative method for infectious diseases
4. New mechanism for cancer progression discovered by UNC and Harvard researchers
5. Researchers identify physiological evidence of chemo brain
6. Researchers find chemical switches for neurodegenerative diseases
7. Release all Tamiflu data as promised, argue researchers
8. Researchers link new molecular culprit to breast cancer progression
9. Researchers discover gender-based differences in Alzheimers disease
10. Researchers find evidence that brain compensates after traumatic injury
11. Researchers find decline in availability and use of key treatment for depression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers report first success of targeted therapy in most common non-small cell lung cancer
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company ... to follow it on Facebook, Twitter, and Pinterest. The fans ... Angelweddingdress draws a lottery every week. , Moreover, the company ... 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... 22, 2015 A new white paper ... and person-centeredness in the long-term care environment as well ... the continuum. The paper, “The Power of Person-Centeredness in ... and practices of the patient, resident and family experience ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
(Date:1/22/2015)... Four years since the release of their debut recording ... marriage of Avasa & Matthew Love – the duo are pleased ... release through White Swan Records on February 24, 2015. , THE ... path available to all of us to walk out of the ...
(Date:1/22/2015)... released a new blog post presenting a list of vehicles that ... , Some types of vehicles cannot be covered under an ordinary ... to see if their vehicle qualifies for auto insurance coverage. ... cars that cannot be covered by a plan. Clients have little ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Recognize Emotions , ... New York, NY (PRWEB) January ... real human face - and she has proven amazingly effective in ... , , ,Sally is one of eight lovable cartoon characters starring ...
... Corp. (Nasdaq: HMSY ) today announced it is ... 31, 2008. Due to better than forecasted business performance for ... 2008 full year EPS guidance from $0.77 to a range ... fourth quarter 2008 EPS range of $0.24 - $0.25. The ...
... Jan. 13 The National Alliance on Mental Illness ... selection of NAMI Montana executive director, Matt Kuntz, to ... and Washington, D.C. en route to Obama,s inauguration.Kuntz is ... who have made "extraordinary contributions" to national life. He ...
... NEW YORK, Jan. 13 Crystal Research Associates, LLC,announced ... on BELLUS Health Inc. (BLU: TSX). The full 52-page ... BELLUS Health Inc. ("BELLUS Health" or ... innovative pharmaceutical and nutraceutical,solutions for critical unmet needs. BELLUS ...
... broad-based,efforts to improve the lives of the most vulnerable ... Maine, is the recipient of the,prestigious 2008 Foster G. ... most esteemed community service honors in health care. , ... is presented to a health care organization,that provides innovative ...
... KENNEBUNK, Maine, Jan. 13 The new year brings ... its steadfast commitment to community programs. This month, the ... brings everyday Americans and local communities together with Tom,s ... care for families in need. Over the past four ...
Cached Medicine News:Health News:Can a Cartoon Aid Children with Autism? 2Health News:Can a Cartoon Aid Children with Autism? 3Health News:Obama Honors NAMI's Matt Kuntz in Whistle Stop Tour to Inauguration; Veterans & PTSD 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. 3Health News:St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 2Health News:St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 3Health News:St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 4Health News:St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 5Health News:St. Mary's Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service 6Health News:Tom's of Maine Invites Everyone to Start the New Year by Helping Families in Need 2
(Date:1/23/2015)... Jan. 23, 2015 Research and Markets ( http://www.researchandmarkets.com/research/vzhr6h/video ... Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... Video communication has been the topic of fascination since the ... States and the Soviet Russia. Earlier even a ...
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... baseball,s all-time hits leader, is the new spokesperson for the ... has announced. "Pete,s a Hall of Famer in ... board with Myoflex," said Ducere Pharma Chief Executive Officer ... known across all generations. The passion and intensity that Pete ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2
... of,coronary artery disease (CAD) appears to be shifting away ... in The,American Journal of Cardiology. , U.S. hospitalization rates ... 2002 to 2005, possibly due,to broader use of preventive ... declines in risk factors like smoking. , The study ...
... Studies Presented at the Targeted,Anticancer Therapies (TAT ... Cancer Meetings Support Phase 1 Trial Design, ... -- Sunesis Pharmaceuticals, Inc. , presented,non-clinical data ... scientific meetings focused on targeted anticancer,medicines. Findings ...
Cached Medicine Technology:Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
For the quantitative in vitro determination of Phenytoin in human serum....
For the quantitative in vitro determination of Microalbumin in human urine....
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with kaolin activator....
Medicine Products: